Three Horizons Framework
for Manufacture of other chemical products n.e.c. (ISIC 2029)
The chemical industry (ISIC 2029) is characterized by high capital expenditures for R&D and production (IN05), long product development cycles, and significant regulatory oversight (IN04, CS06). Simultaneously, it faces intense competitive pressure (MD07) and rapid shifts towards sustainability and...
Short, medium, and long-term strategic priorities
Focus on optimizing current production processes, ensuring strict regulatory compliance, and enhancing supply chain resilience for existing specialty chemical products to maintain profitability and market share. Success means protecting core assets and market positions amidst operational and market pressures.
- Implement advanced process control and automation for high-volume production lines (e.g., industrial adhesives, printing inks) to reduce operational expenditure and waste.
- Diversify sourcing strategies for critical raw materials (e.g., specialty monomers, specific catalysts) to mitigate 'Structural Supply Fragility' (FR04) and ensure production continuity.
- Proactively adapt product formulations and manufacturing practices to comply with evolving global chemical regulations (e.g., REACH updates, specific substance bans) to maintain market access and avoid penalties.
- Enhance product stewardship programs and lifecycle assessments for core products to address customer demands for transparency and demonstrate environmental responsibility.
Invest in and scale emerging product lines and technologies that leverage existing R&D capabilities and market channels, targeting adjacent growth opportunities driven by sustainability trends and advanced material demands. Success is marked by new revenue streams and diversified product offerings.
- Develop and commercialize bio-based or recycled content specialty chemicals (e.g., bio-adhesives, green solvents, recycled polymer additives) to capture market share in sustainable solutions.
- Expand product portfolio into high-growth, technology-driven sectors such as advanced materials for electric vehicles (e.g., battery electrolytes, thermal management fluids) or semiconductor manufacturing (e.g., ultra-pure chemicals, photoresists).
- Pilot and scale chemical recycling technologies for specific plastic wastes (e.g., depolymerization of polyesters, pyrolysis of mixed plastics) to create new feedstock streams and circular economy offerings.
- Establish strategic partnerships or joint ventures with technology developers for advanced analytical techniques or AI/ML-driven material discovery to accelerate R&D cycles (IN05).
Explore genuinely disruptive technologies and business models that could redefine the chemical industry, focusing on long-term sustainability, radical efficiency gains, and entirely new functionalities. Success is building a robust optionality pipeline for future transformative growth.
- Fund fundamental research into advanced catalytic systems and novel synthesis methods (e.g., flow chemistry, electrochemistry) for precise, energy-efficient chemical production.
- Invest in technologies for direct air capture or industrial CO2 utilization as chemical feedstocks (e.g., for methanol, specialty polymers) to address 'Development Program & Policy Dependency' (IN04) and long-term resource scarcity.
- Explore and prototype 'Chemicals-as-a-Service' business models, where functional performance (e.g., lubrication, coating effectiveness) is delivered rather than bulk chemical sales, leveraging IoT and data analytics.
- Engage in academic and startup collaborations focused on quantum chemistry, nanotechnology applications, or self-assembling molecular systems for next-generation material properties.
Strategic Overview
The Three Horizons Framework is critically important for the 'Manufacture of other chemical products n.e.c.' industry due to its capital-intensive nature, long R&D cycles, and the accelerating pace of technological and regulatory change. This framework enables companies to systematically manage innovation across short-term optimization (Horizon 1), mid-term growth (Horizon 2), and long-term disruptive opportunities (Horizon 3). This balanced approach directly addresses challenges such as 'High R&D Investment Risk' (MD01), 'Maintaining Product Portfolio Relevance' (MD01), and the significant 'R&D Burden & Innovation Tax' (IN05) inherent in the chemical sector.
By clearly delineating investments and governance for each horizon, companies can ensure they are optimizing current product lines for profitability while simultaneously exploring new chemical platforms, sustainable alternatives, and novel applications that will define future growth. This strategic foresight is essential for mitigating the risk of 'Stranded Assets' (MD01) and ensuring long-term competitiveness in a market increasingly influenced by 'Development Program & Policy Dependency' (IN04) and 'Structural Toxicity & Precautionary Fragility' (CS06) pressures.
4 strategic insights for this industry
Strategic Allocation to Mitigate R&D Risk and Obsolescence
The framework allows for a structured allocation of R&D budgets and strategic attention across different time horizons. H1 focuses on incremental improvements to existing chemical products and processes, ensuring current profitability. H2 involves developing new formulations, applications, or regional expansions for core chemical families. H3 explores entirely new chemical platforms, radical green chemistry technologies, or disruptive material science, explicitly addressing 'High R&D Investment Risk' (MD01) and 'Maintaining Product Portfolio Relevance' (MD01) by ensuring continuous renewal.
Addressing 'Stranded Assets' Proactively
For an industry with significant fixed assets (e.g., specialized manufacturing plants for specific chemistries), the H3 horizon is crucial for identifying and investing in future-proof technologies (e.g., bio-fermentation, advanced recycling) that can replace or supplement current, potentially carbon-intensive or less sustainable processes. This proactive approach helps mitigate the risk of 'Stranded Assets' (MD01) by anticipating regulatory changes (IN04) and market shifts towards circularity and decarbonization.
Navigating Regulatory and Policy-Driven Innovation
Innovation in the chemical sector is heavily influenced by 'Development Program & Policy Dependency' (IN04) and 'Structural Toxicity & Precautionary Fragility' (CS06). The Three Horizons allows companies to align H2 and H3 initiatives with emerging regulatory frameworks (e.g., REACH, carbon taxes, circular economy mandates) and government funding for green chemistry. This ensures that R&D investments are not only technologically advanced but also compliant and benefit from policy support, reducing 'Regulatory Uncertainty & Market Access Risk' (CS06).
Structured Approach to Innovation 'Tax' and Long Cycles
Given the 'High Capital & Operational Expenditure' and 'Long Development Cycles & Market Risk' (IN05), the framework provides a disciplined way to manage these costs. H1 initiatives yield short-term returns to fund H2 and H3. H2 projects have defined milestones and investment gates, while H3 explorations can be structured as smaller, agile ventures with clear off-ramps if potential proves limited. This minimizes the 'R&D Burden' by ensuring strategic resource allocation and clear decision points.
Prioritized actions for this industry
Formalize Horizon-Specific Innovation Portfolios and Governance
Create distinct portfolios and governance structures for each horizon. H1 projects should be managed for efficiency and immediate ROI. H2 requires dedicated teams with slightly higher risk tolerance, focused on scaling new applications. H3 needs a 'venture-like' approach, allowing for experimentation and failure. This ensures appropriate resource allocation and decision-making for each stage of innovation, addressing 'High R&D Investment Risk' (MD01) and 'R&D Burden' (IN05).
Allocate Proportional R&D Budget by Horizon
Systematically allocate a specific percentage of the total R&D budget to each horizon (e.g., 70% H1, 20% H2, 10% H3). This prevents the common pitfall of H1 projects consuming all resources and starving H2/H3, which is critical for preventing 'Market Obsolescence' (MD01) and ensuring future growth.
Establish External Collaboration & Corporate Venturing for H2/H3
Leverage open innovation, partnerships with startups, universities, and research institutions, or establish a corporate venturing unit to explore H2 and especially H3 opportunities. This can accelerate innovation, reduce internal R&D costs, and bring in external perspectives to address 'Technology Adoption & Legacy Drag' (IN02) and 'R&D Burden' (IN05) more efficiently.
Integrate Scenario Planning with Horizon-Based Strategy
Use scenario planning to stress-test H2 and H3 initiatives against various future possibilities (e.g., aggressive carbon taxation, rapid bio-based material adoption, new regulatory regimes). This helps refine innovation pathways, identify robust options, and proactively mitigate risks associated with 'Development Program & Policy Dependency' (IN04) and 'Structural Toxicity' (CS06), ensuring investments are resilient.
From quick wins to long-term transformation
- Categorize all current R&D projects and major operational initiatives into H1, H2, or H3 to get an immediate snapshot of the current portfolio balance.
- Communicate the Three Horizons concept internally to senior leadership and key stakeholders to build a shared understanding of strategic priorities.
- Identify one or two 'quick win' H2 projects (e.g., new application for an existing product) to demonstrate the value of expanding beyond H1.
- Develop specific KPIs and success metrics for each horizon, differentiating between efficiency for H1 and learning/option value for H3.
- Form cross-functional 'Horizon 2' teams with dedicated resources, allowing them some autonomy from day-to-day H1 operations.
- Conduct a 'future trends' workshop involving external experts to inform potential H3 areas, especially concerning sustainability and digital transformation.
- Embed horizon thinking into the annual strategic planning cycle, ensuring long-term vision guides resource allocation and portfolio management.
- Establish a dedicated 'Horizon 3' incubator or venture fund to actively invest in and nurture disruptive chemical technologies or business models.
- Develop a structured 'sunset' or 'divestment' process for H1 products/technologies that are no longer viable, freeing up resources for H2/H3.
- H1 bias: The immediate demands of the core business consume disproportionate resources, starving H2 and H3 initiatives.
- Lack of distinct governance: Applying H1 metrics and management styles to H2/H3 projects, stifling innovation and discouraging risk-taking.
- Insufficient funding or commitment: H2/H3 projects are under-resourced or treated as 'pet projects' without serious strategic intent.
- Poor transition management: Failure to successfully scale H2 initiatives into H1 status or integrate H3 breakthroughs into core operations.
- No 'kill' criteria: Holding onto underperforming H2/H3 projects for too long, wasting valuable resources.
Measuring strategic progress
| Metric | Description | Target Benchmark |
|---|---|---|
| Innovation Portfolio Balance (by Horizon) | Percentage of R&D budget, personnel, or project count allocated to Horizon 1, 2, and 3 initiatives. | Achieve a target allocation (e.g., 70% H1, 20% H2, 10% H3) and maintain within +/- 5% annually. |
| % Revenue from New Products (H2/H3) | Percentage of total company revenue generated by products launched in the last 3-5 years, representing successful H2 and early H3 commercialization. | Increase revenue from H2/H3 products by 2% year-over-year, aiming for 15-20% of total revenue within 5 years. |
| R&D Return on Investment (ROI) by Horizon | Measures the financial return generated by R&D investments within each horizon, acknowledging different risk and time profiles (e.g., H1: profit margin, H3: option value/IP acquisition). | H1: Maintain >15% ROI; H2: Achieve >8% ROI within 3 years of launch; H3: Track successful progression to H2 or strategic learning outcomes. |
| Time-to-Market for H2 Initiatives | The average time taken from concept to commercial launch for products categorized under Horizon 2. | Reduce H2 time-to-market by 10-15% over 3 years, leveraging agile development where possible. |
Other strategy analyses for Manufacture of other chemical products n.e.c.
Also see: Three Horizons Framework Framework